INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 130 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q2 2023 | $3 | -40.0% | 6 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | -44.4% | 6 | 0.0% | 0.00% | – |
| Q4 2022 | $9 | – | 6 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 6 | -98.3% | 0.00% | -100.0% |
| Q1 2021 | $3,000 | 0.0% | 344 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | -25.0% | 338 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -55.6% | 338 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $9,000 | +200.0% | 338 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $3,000 | +200.0% | 338 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 338 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 338 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 338 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 338 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 338 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | +100.0% | 338 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 338 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $2,000 | +100.0% | 338 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 338 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $2,000 | -33.3% | 338 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $3,000 | +50.0% | 338 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $2,000 | 0.0% | 338 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -33.3% | 338 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $3,000 | 0.0% | 338 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | 0.0% | 338 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | +50.0% | 338 | 0.0% | 0.00% | +100.0% |
| Q4 2015 | $2,000 | 0.0% | 338 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $2,000 | -33.3% | 338 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $3,000 | – | 338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Triatomic Management LP | 235,000 | $405,000 | 0.23% |
| Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
| Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
| Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
| Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
| Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
| CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
| Keystone Financial Group | 74,058 | $128,000 | 0.03% |
| Virtu Financial LLC | 130,829 | $226,000 | 0.02% |